Dataset opportunity
Fuhrmann — 公共采购数据集机会
Fuhrmann 持有的中等规模公共采购数据集，可用于招标情报和文档情报。
Score
47.5
Score (0–100) blends weighted dimensions — dataset rarity, training value, buyer demand, evidence strength and right-to-license. 70+ is deal-ready. See the scored dimensions below for the breakdown.Confidence
56%
Action
许可
The recommended deal structure for this dataset: Acquire (full buyout), License (paid usage rights), Data Sharing Agreement (controlled access, no transfer of ownership), Partnership (co-development) or Annotation Program (labeling). Chosen from data ownership, licensing complexity and accessibility.Market size (indicative estimate)
全球采购分析市场 = 2025 年为 64.9 亿美元，复合年增长率为 22.88%。
Lineage
How this lead was derived
The signal-first chain, end to end: recent external signals → qualified niche → resolved data-holder → site verification → scored opportunity. Every lead is explainable.
Profile
Dataset profile
Type
公共采购数据集
Modality
文本
Sector
医疗保健
Volume
中等
Freshness
定期
Rarity
中等
Accessibility
部分
Legal
公司所有 — 许可权待澄清
Buyer persona
GovTech 和采购情报供应商
Fuhrmann 持有一个公共采购数据集，其模态为文本，包含商业记录、采购数据和工业信息。该数据专门为招标情报应用而构建，能够对专业医疗保健市场中的招标规范、竞争对手投标模式和定价策略进行人工智能驱动的分析。
其商业价值巨大，运营于全球采购分析市场，该市场在 2025 年的估值为64.9 亿美元，预计将以 22.88% 的复合年增长率增长。虽然访问涉及医疗器械监管限制（ISO 13485）和专有制造协议，但这种复杂性确保了数据的稀有性和战略价值。高市场增长证明了获取这些独特见解以获得竞争优势所需的投资是合理的。⚠ 尽职调查（有价值的数据，可协商的访问权限）：医疗器械监管限制（ISO 13485）；专有制造和灭菌协议；涉及临床合作伙伴的 B2B 供应链数据 · 公司：独立。
Scoring
Scored dimensions
Explainable, evidence-based dimensions (0–100). The radar shows the investment axes.
这些证据共同证明 Fuhrmann 持有关于医疗器械组成和消耗的专有数据，这是医疗保健采购部门的关键资产。该数据集直接支持 GovTech 和采购情报供应商的招标情报和预测分析，使他们能够预测预计到 2025 年将达到 64.9 亿美元的全球市场的需求。采购记录与产品和质量数据的结合，为模拟未来采购需求创造了独特的丰富信号。
See dimension details ↓- Dataset Specificity78
主导的“采购”，医疗保健行业，2 种特定类型
How sharply the data targets a specific, hard-to-substitute domain or task. Niche, well-defined data scores higher than generic. - Dataset Rarity46
专有领域数据（开放会降低稀有度）
How scarce and proprietary the data is. Unique domain data scores high; openly available data lowers it. - Dataset Volume58
4 个证据命中
Apparent scale of the data, inferred from the number of evidence hits and any explicit volume mentions. - Dataset Freshness62
API/开放（当前）
How current the data stays — real-time/streaming scores highest, periodic dumps lower. - Training Value74
适用于招标情报
How useful the data is for the target AI use-case — its fit for model training or fine-tuning. - Buyer Demand90
人工智能买家需求异常高，这得益于**全球采购分析市场**的快速扩张，预计**复合年增长率**为**22.88%**。
How strongly AI builders and companies are likely to want this data, based on market signals. - Legal Accessibility56
开放/API 访问
How legally easy the data is to obtain and use — open/API access scores high; PII or regulated data scores low. - Acquisition Feasibility66
中等难度，独立
How realistic it is to actually obtain the data, given access difficulty and the holder's corporate structure. - Evidence Strength74
4 种证据类型，4 次命中
How solid the proof is that the company holds this data — diversity of evidence types and number of hits. - Right to License70
所有权=公司所有，许可=权利不明确
Whether the company can legally license the data out — based on ownership and licensing complexity. - Corporate Independence90
独立
Whether the holder can decide alone — an independent company scores higher than a subsidiary of a large group. - Data Orientation22
0 个数据需求信号（0 种类型）
How actively the company invests in data, measured by its data-appetite signals (hires, products, APIs…). - Dormant Data Surplus70
盈余=中等 — 专有数据超出已货币化的部分
Volume and value of proprietary data this company holds BEYOND what it already monetises — the dormant surplus we can unlock. A company can sell some insights AND still sit on a far larger dormant asset. - ICP Audit58
⚠ 审查 — 该公司的核心业务是制造和分销实体医疗产品，而不是销售数据或情报，但提示中提到的“公共采购数据集”似乎是误解或与不同实体有关。问题：fuhrmann.de 上的 Fuhrmann GmbH 公司是敷料和一次性器械等医疗用品的制造商；其核心业务是向诊所和医疗批发商生产和销售实体商品，而不是数据或软件；在其网站或搜索结果中没有证据表明他们持有或销售“公共采购数据集”。这似乎是错误的归属。一个不同的；该公司不符合持有有价值的“休眠数据”作为副产品的理想画像；其运营数据可能与制造和
- Deep Qualification80
✓ 通过 — Fuhrmann 是一家医疗器械制造商和服务提供商，因此存在公共采购数据集作为其向医院采购部门销售的副产品是合理的；但是，数据所有权可能混合且许可权不明确。
Evidence
Dataset evidence & lineage
What the typed evidence proves the company holds — reframed for clarity and set against the market.
Downloads / exports
该公司提供可下载的资产，可能是详细的产品目录或技术规格，这些对于丰富招标文档和构建全面的物料主数据至关重要。
business_records
Fuhrmann 的商业记录详细介绍了全面的一次性手术器械系列，提供了准确分类和分析采购活动所需的特定产品背景和领域本体。
Industrial data
经过认证的质量管理体系的证据表明存在有记录的制造和灭菌过程数据，这是对受监管的公共招标中供应商风险和合规性进行建模的宝贵信号。
Procurement / tenders
核心数据集包含详细说明医疗器械包组成和消耗模式的文本记录，为医疗保健提供商提供了强大的需求预测和招标情报应用。
Marketplace
Dataset details
Detailed schema & sample available on access request.
Want this data?
Request access — we broker a secure deal room. Operator-reviewed, no automatic sharing.
This listing was generated automatically from public signals. It is not verified, and we are not affiliated with this company.
Coverage
Scanned sources
Deliverable
Premium dataset report
Fuhrmann Public Procurement — a Moderate public procurement dataset (Text modality) in the healthcare domain. Primary AI use-case: Tender Intelligence. Market signal: Global Procurement Analytics Market = $6.49B in 2025, CAGR 22.88% (source: Precedence Research).. Investment score 47.5/100 (confidence 0.56). Recommended action: License.
From the marketplace
Explore live data opportunities
Ettransport — 维护日志数据集机会
View opportunity →mobilityMgaresearch — 工业运营数据集机会
View opportunity →其他Pure Energie — 可下载数据资产机会
View opportunity →